China · Delayed Price · Currency is CNY Boji Medical Technology Statistics
Total Valuation
SHE:300404 has a market cap or net worth of CNY 4.97 billion. The enterprise value is 4.63 billion.
| Market Cap | 4.97B |
| Enterprise Value | 4.63B |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | Jun 17, 2026 |
Share Statistics
SHE:300404 has 383.08 million shares outstanding. The number of shares has increased by 0.26% in one year.
| Current Share Class | 383.08M |
| Shares Outstanding | 383.08M |
| Shares Change (YoY) | +0.26% |
| Shares Change (QoQ) | -0.25% |
| Owned by Insiders (%) | 34.44% |
| Owned by Institutions (%) | 2.30% |
| Float | 245.91M |
Valuation Ratios
The trailing PE ratio is 95.54.
| PE Ratio | 95.54 |
| Forward PE | n/a |
| PS Ratio | 5.17 |
| PB Ratio | 4.46 |
| P/TBV Ratio | 4.80 |
| P/FCF Ratio | 92.88 |
| P/OCF Ratio | 72.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 66.80, with an EV/FCF ratio of 86.63.
| EV / Earnings | 88.91 |
| EV / Sales | 4.82 |
| EV / EBITDA | 66.80 |
| EV / EBIT | 110.33 |
| EV / FCF | 86.63 |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.04.
| Current Ratio | 1.92 |
| Quick Ratio | 1.41 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.62 |
| Debt / FCF | 0.81 |
| Interest Coverage | 54.27 |
Financial Efficiency
Return on equity (ROE) is 4.94% and return on invested capital (ROIC) is 5.27%.
| Return on Equity (ROE) | 4.94% |
| Return on Assets (ROA) | 1.61% |
| Return on Invested Capital (ROIC) | 5.27% |
| Return on Capital Employed (ROCE) | 3.63% |
| Weighted Average Cost of Capital (WACC) | 5.73% |
| Revenue Per Employee | 802,451 |
| Profits Per Employee | 43,510 |
| Employee Count | 1,198 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, SHE:300404 has paid 3.37 million in taxes.
| Income Tax | 3.37M |
| Effective Tax Rate | 5.97% |
Stock Price Statistics
The stock price has increased by +19.21% in the last 52 weeks. The beta is 0.28, so SHE:300404's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +19.21% |
| 50-Day Moving Average | 11.07 |
| 200-Day Moving Average | 10.34 |
| Relative Strength Index (RSI) | 50.94 |
| Average Volume (20 Days) | 56,870,092 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300404 had revenue of CNY 961.34 million and earned 52.12 million in profits. Earnings per share was 0.14.
| Revenue | 961.34M |
| Gross Profit | 238.84M |
| Operating Income | 42.01M |
| Pretax Income | 56.47M |
| Net Income | 52.12M |
| EBITDA | 68.13M |
| EBIT | 42.01M |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 408.29 million in cash and 43.34 million in debt, with a net cash position of 364.95 million or 0.95 per share.
| Cash & Cash Equivalents | 408.29M |
| Total Debt | 43.34M |
| Net Cash | 364.95M |
| Net Cash Per Share | 0.95 |
| Equity (Book Value) | 1.11B |
| Book Value Per Share | 2.84 |
| Working Capital | 493.49M |
Cash Flow
In the last 12 months, operating cash flow was 68.86 million and capital expenditures -15.36 million, giving a free cash flow of 53.50 million.
| Operating Cash Flow | 68.86M |
| Capital Expenditures | -15.36M |
| Depreciation & Amortization | 26.12M |
| Net Borrowing | -2.35M |
| Free Cash Flow | 53.50M |
| FCF Per Share | 0.14 |
Margins
Gross margin is 24.84%, with operating and profit margins of 4.37% and 5.42%.
| Gross Margin | 24.84% |
| Operating Margin | 4.37% |
| Pretax Margin | 5.87% |
| Profit Margin | 5.42% |
| EBITDA Margin | 7.09% |
| EBIT Margin | 4.37% |
| FCF Margin | 5.56% |
Dividends & Yields
This stock pays an annual dividend of 0.01, which amounts to a dividend yield of 0.08%.
| Dividend Per Share | 0.01 |
| Dividend Yield | 0.08% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 20.71% |
| Buyback Yield | -0.26% |
| Shareholder Yield | -0.18% |
| Earnings Yield | 1.05% |
| FCF Yield | 1.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 2, 2022. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 2, 2022 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |